Arjo AB (FRA:A39) ROCE %: 6.86% (As of Mar. 2026)


FRA:A39 Arjo AB FRA:A39
73 GF Score
Price €2.21
GF Value €3.24
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Arjo AB ROCE %?

Arjo AB FRA:A39 +1.10% 73 ROCE % is 6.86% as of Mar. 2026. GuruFocus rates FRA:A39 with a GF Score™ of 73/100 and a GF Value™ of €3.24 (Significantly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Arjo AB's annualized ROCE % for the quarter that ended in Mar. 2026 was 6.86%.

Arjo AB  (FRA:A39) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Arjo AB ROCE % Related Terms

Arjo AB ROCE % Historical Data

* Premium members only.

The historical data trend for Arjo AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arjo AB ROCE % Chart

Arjo AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.90 7.19 7.99 8.12 6.08

Arjo AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.57 7.31 5.64 8.78 6.86
FRA:A39
73GF Score
Arjo AB FRA:A39
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arjo AB ROCE % Calculation

Arjo AB's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=62.211/( ( (1414.982 - 399.648) + (1376.269 - 345.423) )/ 2 )
=62.211/( (1015.334+1030.846)/ 2 )
=62.211/1023.09
=6.08 %

Arjo AB's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=70.928/( ( (1376.269 - 345.423) + (1436.87 - 398.744) )/ 2 )
=70.928/( ( 1030.846 + 1038.126 )/ 2 )
=70.928/1034.486
=6.86 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.86% mean?
Arjo AB (FRA:A39) has a ROCE % of 6.86% as of Mar. 2026.
Is Arjo AB's ROCE % too high?
Arjo AB's current ROCE % is 6.86%. The Medical Distribution industry median ROCE % is 9.22. Arjo AB's value of 6.86% is 25.6% below this industry median. Overall, Arjo AB has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Arjo AB's ROCE % compare to MCK and COR?
Arjo AB's ROCE % of 6.86% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.22. Arjo AB's value of 6.86% is 25.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.22, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arjo AB's current ROCE % of 6.86% is 25.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arjo AB's current ROCE % is 6.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arjo AB stock overvalued right now?
Based on GuruFocus' analysis, Arjo AB (FRA:A39) is currently considered Significantly Undervalued. The stock's GF Value™ is €3.24, compared to a current price of €2.21 — trading 31.7% below its estimated fair value. The current ROCE % is 6.86% and 25.6% below the Medical Distribution industry median of 9.22. Arjo AB's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Arjo AB (FRA:A39), the current ROCE % is 6.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arjo AB (FRA:A39) Overvalued in 2026?

Based on GuruFocus' analysis, Arjo AB stock appears to be undervalued. The current stock price of €2.21 is trading 31.7% below its estimated GF Value™ of €3.24. GuruFocus considers Arjo AB to be Significantly Undervalued.

Key valuation signals for FRA:A39:

  • ROCE %: 6.86%
  • GF Value™: €3.24 vs. price of €2.21 (31.7% below fair value)
  • GF Score™: 73/100 with 5 warning signs
  • Industry Position: 25.6% below the Medical Distribution median

No single metric tells the full story. See the FRA:A39 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arjo AB Business Description

Address Hans Michelsensgatan 10, Box 48, Malmo, SWE, SE-201 20
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. The company includes segments: Global Sales, North America, Diagnostics.
73GF Score

Get the complete analysis for FRA:A39

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.21
Price
€3.24
GF Value